Stocks are rising in intraday trading as investors received positive COVID-19 vaccine news for the third Monday in a row.
According to a press release, AstraZeneca and the University of Oxford's vaccine candidate was found in a large trial to have "showed vaccine efficacy of 90% when [the candidate] was given as a half dose, followed by a full dose at least one month apart, and another dosing regimen showed 62% efficacy when given as two full doses at least one month apart. The combined analysis from both dosing regimens resulted in an average efficacy of 70%."
Wondering why Jim Cramer is wearing a mask? Find out why on xprize.org.
And members can get updates on Cramer's stocks and his latest moves over on Action Alerts PLUS.